Corpus Engine Towards a reproducible .science file.
← All .science files

pmid:32528308

Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy.

Li-Yen R Hu · Aikaterini Kontrogianni-Konstantopoulos

Frontiers in physiology · 2020 doi:10.3389/fphys.2020.00478

Paper

complete

Experiment

complete

Data

partial

Analysis

complete

Execution

absent

Execution evidence has not yet been added to this .science file. Explore its methods, data and open questions to plan the next step.
Record details sci_version · id · kind · revision · content_hash · schema · created_at · updated_at · generator
id
pmid:32528308
kind
science-record
content_hash
sha256:a864d0a98bf74d2c1af7a5e1e82304ea47365a14b1f5b1b899d654a45a783496
schema
https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json
created_at
2026-11-01T15:41:03Z
updated_at
2026-11-01T22:44:57Z
generator object · 2 fields
name
corpus-assay-engine
run_id
reading-sci-2026-11-01
paper object · 10 fields
state
complete
title
Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy.
doi
10.3389/fphys.2020.00478
pmid
32528308
authors array · 2 items
[0]
Li-Yen R Hu
[1]
Aikaterini Kontrogianni-Konstantopoulos
journal
Frontiers in physiology
year
2020
abstract
Obscurin is a giant cytoskeletal protein with structural and regulatory roles encoded by the OBSCN gene. Recently, mutations in OBSCN were associated with the development of different forms of cardiomyopathies, including hypertrophic cardiomyopathy (HCM). We previously reported that homozygous mice carrying the HCM-linked R4344Q obscurin mutation develop arrhythmia by 1-year of age under sedentary conditions characterized by increased heart rate, frequent incidents of premature ventricular contractions, and episodes of spontaneous ventricular tachycardia. In an effort to delineate the molecular mechanisms that contribute to the observed arrhythmic phenotype, we subjected protein lysates prepared from left ventricles of 1-year old R4344Q and wild-type mice to comparative proteomics analysis using tandem mass spectrometry; raw data are available via ProteomeXchange with identifier PXD017314. We found that the expression levels of proteins involved in cardiac function and disease, cytoskeletal organization, electropotential regulation, molecular transport and metabolism were significantly altered. Moreover, phospho-proteomic evaluation revealed changes in the phosphorylation profile of Ca2+ cycling proteins, including sAnk1.5, a major binding partner of obscurin localized in the sarcoplasmic reticulum; notably, this is the first report indicating that sAnk1 undergoes phosphorylation. Taken together, our findings implicate obscurin in diverse cellular processes within the myocardium, which is consistent with its multiple binding partners, localization in different subcellular compartments, and disease association.
claims array · 2 items
[0] object · 6 fields
id
claim-method
statement
A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States).
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32528308
locator
sections[6] "Data Analysis" paragraph 2
quote
A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States).
state
complete
[1] object · 6 fields
id
claim-data-access
statement
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.
kind
methodological
target
null
evidence array · 1 item
[0] object · 3 fields
asset
source:pmid:32528308
locator
sections[16] "Data Availability Statement" paragraph 2
quote
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.
state
complete
gaps array · 0 items
experiment object · 8 fields
state
complete
objective
null
steps array · 3 items
[0] object · 13 fields
id
read_published_estimate
order
1
name
Read the published estimate from the source
kind
other
state
complete
blocked_on
null
description
The claim, method and evidence span published with the source article.
parameters object · 0 fields
inputs array · 1 item
[0]
source:pmid:32528308
outputs array · 1 item
[0]
the published estimate and its evidence
instruments array · 0 items
reagents array · 0 items
[1] object · 13 fields
id
obtain_source_data
order
2
name
Obtain the source data from the named repository
kind
data-preparation
state
complete
blocked_on
null
description
The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD017314
outputs array · 1 item
[0]
the source data with its repository provenance
instruments array · 0 items
reagents array · 0 items
[2] object · 13 fields
id
run_analysis
order
3
name
Run the published analysis
kind
analysis
state
complete
blocked_on
null
description
Apply the paper's statistical method to the resolved series and compare the result with the published target.
parameters object · 0 fields
inputs array · 1 item
[0]
data:geo:PXD017314
outputs array · 1 item
[0]
the replicated result and its comparison
instruments array · 0 items
reagents array · 0 items
materials array · 0 items
instruments array · 0 items
reagents array · 0 items
conditions object · 0 fields
gaps array · 0 items
data object · 3 fields
state
partial
assets array · 9 items
[0] object · 15 fields
id
source:pmid:32528308
role
manuscript
format
xml
media_type
application/xml
uri
https://doi.org/10.3389/fphys.2020.00478
sha256
sha256:b66c02e467a0cbb74ae81161f02b099e3740a01d83d31748c2cd8a886ff1b32d
bytes
71142
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
10.3389/fphys.2020.00478
version
null
note
Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.
structure object · 4 fields
pmcid
PMC7247546
source
europe_pmc_fulltext
coverage
whole_body
text_hash_scope
rendered_section_body
[1] object · 15 fields
id
data:geo:PXD017314
role
raw
format
geo-series
media_type
application/vnd.ncbi.geo-series+json
uri
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD017314
sha256
null
bytes
null
access
open
state
resolved
reader
null
reader_status
reader_required
identifier
PXD017314
version
null
note
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.
structure object · 15 fields
repository
GEO
access_route
GEO accession URL
access_statement_verbatim
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.
access_statement_kind
data_availability_statement
sample_accessions array · 0 items
sample_count
null
group_sizes
null
group_sizes_basis
null
platform
null
taxon
null
title
Proteomic analysis of left ventricles containing the obscurin R4344Q mutation linked to hypertrophic cardiomyopathy and myocardia containing obscurin lacking Immunoglobulin domains 58/59 (Ig58/59)
resolution_checked_at
2026-10-31T18:35:55Z
resolution_check
identifier_resolution_only_no_download_no_licence_read
downloaded
false
licence_read
false
[2] object · 16 fields
id
asset:table:pmid:32528308:1
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:3a8f47a125ef163414008ea0dd425aedcccd783a0013d0c80d8d9e1a4aa46ca2
bytes
2049
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[8]/table-wrap[1]#T1
version
null
note
Altered expression levels of proteins involved in cardiac function and disease.
structure object · 5 fields
pmcid
PMC7247546
section_index
8
section_title
Results and Discussion
row_count
17
column_count
7
table object · 8 fields
label
TABLE 1
caption
Altered expression levels of proteins involved in cardiac function and disease.
rows array · 17 items
[0] array · 7 items
[0]
Gene
[1]
Protein
[2]
% Change (95% Confidence interval)
[3]
P-value
[4]
Unique peptides
[5]
Total peptides
[6]
Function or disease
[1] array · 7 items
[0]
CACNA1C
[1]
Calcium channel, voltage-dependent, L-type, alpha 1C subunit
[2]
−16.4(−26.1,−5.6)
[3]
0.0151
[4]
9
[5]
9
[6]
Short QT syndrome; Long QT syndrome
[2] array · 7 items
[0]
KCNQ1
[1]
Potassium channel, voltage-gated, subfamily Q, member 1
[2]
−19.0(−31.6,−4.2)
[3]
0.0253
[4]
1
[5]
1
[6]
[3] array · 7 items
[0]
ANK1
[1]
Small Ankyrin 1.5
[2]
44.0(2.0,103.3)
[3]
0.0426
[4]
1
[5]
3
[6]
Cardiac output
[4] array · 7 items
[0]
DDAH1
[1]
Dimethylarginine dimethylaminohydrolase 1
[2]
45.5(24.1,70.6)
[3]
0.0028
[4]
2
[5]
3
[6]
[5] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4(−60.1,−1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
[6] array · 7 items
[0]
PKG1
[1]
Protein kinase, cGMP-dependent, type 1 (PKG1)
[2]
43.6(1.5,103.1)
[3]
0.0444
[4]
1
[5]
5
[6]
[7] array · 7 items
[0]
KCNQ1
[1]
Potassium channel, voltage-gated, subfamily Q, member 1
[2]
−19.0(−31.6,−4.2)
[3]
0.0253
[4]
1
[5]
1
[6]
Familial atrial fibrillation
[8] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4(−60.1,−1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
[9] array · 7 items
[0]
FHL2
[1]
Four and a half LIM domains 2
[2]
−56.0(−79.7,−4.6)
[3]
0.0422
[4]
5
[5]
5
[6]
Relaxation of aortic ring tissue
[10] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4(−60.1,−1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
[11] array · 7 items
[0]
CACNA1C
[1]
Calcium channel, voltage-dependent, L-type, alpha 1C subunit
[2]
−16.4(−26.1,−5.6)
[3]
0.0151
[4]
9
[5]
9
[6]
Supraventricular tachycardia
[12] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4(−60.1,−1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
[13] array · 7 items
[0]
GUCY1A2
[1]
Guanylate cyclase 1, alpha 2
[2]
−16.2(−28.1,−2.5)
[3]
0.0317
[4]
1
[5]
1
[6]
Acute heart failure
[14] array · 7 items
[0]
MME
[1]
Membrane metallo endopeptidase
[2]
17.3(1.1,36.0)
[3]
0.0407
[4]
2
[5]
2
[6]
[15] array · 7 items
[0]
DYSF
[1]
Dysferlin
[2]
−34.2(−49.5,−14.2)
[3]
0.0118
[4]
40
[5]
42
[6]
Early onset cardiomyopathy
[16] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4(−60.1,−1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
Mild congestive heart failure
locator
section[8]/table-wrap[1]#T1
[3] object · 16 fields
id
asset:table:pmid:32528308:2
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:2e2ca0488c0a60c23c25055da2fa6b60886e5c1a4491b77bbc294756b3a7a34f
bytes
1083
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[1]#T2
version
null
note
Altered expression levels of proteins involved in electropotential regulation.
structure object · 5 fields
pmcid
PMC7247546
section_index
11
section_title
Electropotential Regulation
row_count
8
column_count
7
table object · 8 fields
label
TABLE 2
caption
Altered expression levels of proteins involved in electropotential regulation.
rows array · 8 items
[0] array · 7 items
[0]
Gene
[1]
Protein
[2]
% Change (95% Confidence interval)
[3]
P-value
[4]
Unique peptides
[5]
Total peptides
[6]
Function
[1] array · 7 items
[0]
KCNJ11
[1]
Potassium inwardly rectifying channel, subfamily J, member 11 (Kir6.2)
[2]
17.9 (0.9, 37.8)
[3]
0.0427
[4]
4
[5]
4
[6]
Transmembrane potential of cellular membrane
[2] array · 7 items
[0]
KCNQ1
[1]
Potassium channel, voltage-gated subfamily Q, member 1
[2]
−19.0 (−31.6, −4.2)
[3]
0.0253
[4]
1
[5]
1
[6]
[3] array · 7 items
[0]
PHB
[1]
Prohibitin
[2]
19.8 (6.2, 35.2)
[3]
0.0142
[4]
15
[5]
15
[6]
[4] array · 7 items
[0]
PHB2
[1]
Prohibitin 2
[2]
21.5 (3.4, 42.9)
[3]
0.0288
[4]
20
[5]
20
[6]
[5] array · 7 items
[0]
KCNQ1
[1]
Potassium channel, voltage-gated subfamily Q, member 1
[2]
−19.0 (−31.6, −4.2)
[3]
0.0253
[4]
1
[5]
1
[6]
Flux of potassium
[6] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4 (−60.1, −1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
[7] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4 (−60.1, −1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
Co-transport of chloride
locator
section[11]/table-wrap[1]#T2
[4] object · 16 fields
id
asset:table:pmid:32528308:3
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:c9353cba8cca0bf8f591b491727088ea7fcd9660effb2f9ad63459902d52d8ae
bytes
1949
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[2]#T4
version
null
note
Altered expression levels of proteins involved in molecular transport.
structure object · 5 fields
pmcid
PMC7247546
section_index
11
section_title
Electropotential Regulation
row_count
19
column_count
7
table object · 8 fields
label
TABLE 4
caption
Altered expression levels of proteins involved in molecular transport.
rows array · 19 items
[0] array · 7 items
[0]
Gene
[1]
Protein
[2]
% Change (95% Confidence interval)
[3]
P-value
[4]
Unique peptides
[5]
Total peptides
[6]
Function
[1] array · 7 items
[0]
ABAT
[1]
4-aminobutyrate aminotransferase
[2]
−29.9 (−38.6, −19.9)
[3]
0.0018
[4]
8
[5]
8
[6]
Secretion of molecules
[2] array · 7 items
[0]
CP
[1]
Ceruloplasmin
[2]
40.0 (8.4, 80.9)
[3]
0.0217
[4]
1
[5]
22
[6]
[3] array · 7 items
[0]
KCNJ11
[1]
Potassium inwardly rectifying channel, subfamily J, member 11 (Kir6.2)
[2]
17.9 (0.9, 37.8)
[3]
0.0427
[4]
4
[5]
4
[6]
[4] array · 7 items
[0]
KCNQ1
[1]
Potassium channel, voltage-gated, subfamily Q, member 1
[2]
−19.0 (−31.6, −4.2)
[3]
0.0253
[4]
1
[5]
1
[6]
[5] array · 7 items
[0]
MGLL
[1]
Monoglyceride lipase
[2]
−14.6 (−27.0, −0.1)
[3]
0.0488
[4]
3
[5]
3
[6]
[6] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4 (−60.1, −1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
[7] array · 7 items
[0]
PHB
[1]
Prohibitin
[2]
19.8 (6.2, 35.2)
[3]
0.0142
[4]
15
[5]
15
[6]
[8] array · 7 items
[0]
PLIN2
[1]
Perilipin2
[2]
16.5 (2.7, 32.2)
[3]
0.0280
[4]
5
[5]
5
[6]
[9] array · 7 items
[0]
POFUT2
[1]
Protein O-fucosyltransferase 2
[2]
21.9 (1.3, 46.7)
[3]
0.0411
[4]
3
[5]
3
[6]
[10] array · 7 items
[0]
PKG1
[1]
Protein kinase, cGMP-dependent, type 1 (PKG1)
[2]
43.6 (1.5, 103.1)
[3]
0.0444
[4]
1
[5]
5
[6]
[11] array · 7 items
[0]
PTPN11
[1]
Protein tyrosine phosphatase, non-receptor type 11
[2]
20.8 (9.1, 33.8)
[3]
0.0067
[4]
21
[5]
21
[6]
[12] array · 7 items
[0]
RAB3B
[1]
Rab3b
[2]
−30.3 (−46.0, −10.0)
[3]
0.0172
[4]
1
[5]
2
[6]
[13] array · 7 items
[0]
SIRPA
[1]
Signal-regulatory protein alpha
[2]
17.8 (5.7, 31.3)
[3]
0.0138
[4]
2
[5]
2
[6]
[14] array · 7 items
[0]
TRAF3
[1]
TNF receptor-associated factor 3
[2]
9.1 (0.3, 18.7)
[3]
0.0451
[4]
1
[5]
1
[6]
[15] array · 7 items
[0]
GOT2
[1]
Glutamatic-oxaloacetic transaminase 2, mitochondrial
[2]
−16.8 (−30.0, −1.2)
[3]
0.0408
[4]
29
[5]
29
[6]
Transport of long chain fatty acids
[16] array · 7 items
[0]
PLIN2
[1]
Perillipin2
[2]
16.5 (2.7, 32.2)
[3]
0.0280
[4]
5
[5]
5
[6]
[17] array · 7 items
[0]
SLC27A4
[1]
Solute carrier family 27
[2]
19.4 (0.9, 41.2)
[3]
0.0428
[4]
3
[5]
4
[6]
[18] array · 7 items
[0]
NPPA
[1]
Natriuretic peptide type A
[2]
−37.4 (−60.1, −1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
Flux of water
locator
section[11]/table-wrap[2]#T4
[5] object · 16 fields
id
asset:table:pmid:32528308:4
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:ed0169ce45200f3092472fee9a51af1fd996739d55aaaebb7d3ffc93dd86562b
bytes
3480
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[11]/table-wrap[3]#T5
version
null
note
Altered expression levels of proteins involved in metabolism.
structure object · 5 fields
pmcid
PMC7247546
section_index
11
section_title
Electropotential Regulation
row_count
35
column_count
7
table object · 8 fields
label
TABLE 5
caption
Altered expression levels of proteins involved in metabolism.
rows array · 35 items
[0] array · 7 items
[0]
Gene
[1]
Protein
[2]
% Change (95% Confidence interval)
[3]
P-value
[4]
Unique peptides
[5]
Total peptides
[6]
Function
[1] array · 7 items
[0]
ABAT
[1]
4-aminobutyrate aminotransferase
[2]
−29.9(−38.6,−19.9)
[3]
0.0018
[4]
8
[5]
8
[6]
Catabolism of lipids
[2] array · 7 items
[0]
ACOT7
[1]
Acyl-CoA thioesterase 7
[2]
22.0(1.2,47.2)
[3]
0.0418
[4]
5
[5]
5
[6]
[3] array · 7 items
[0]
DDHD2
[1]
DDHD domain containing 2
[2]
30.4(0.3,69.5)
[3]
0.0486
[4]
1
[5]
1
[6]
[4] array · 7 items
[0]
HEXB
[1]
Hexosaminidase B
[2]
11.5(3.9,19.7)
[3]
0.0129
[4]
3
[5]
3
[6]
[5] array · 7 items
[0]
MGLL
[1]
Monoglyceride lipase
[2]
−14.6(−27.0,−0.1)
[3]
0.0488
[4]
3
[5]
3
[6]
[6] array · 7 items
[0]
SLC27A4
[1]
Solute carrier family 27
[2]
19.4(0.9,41.2)
[3]
0.0428
[4]
3
[5]
4
[6]
[7] array · 7 items
[0]
VLDLR
[1]
Very low density lipoprotein receptor
[2]
7.6(1.2,14.3)
[3]
0.0291
[4]
8
[5]
8
[6]
[8] array · 7 items
[0]
ABAT
[1]
4-aminobutyrate aminotransferase
[2]
−29.9(−38.6,−19.9)
[3]
0.0018
[4]
8
[5]
8
[6]
Metabolism of amino acids
[9] array · 7 items
[0]
BCKDHB
[1]
Branched chain ketoacid dehydrogenase E1, beta polypeptide
[2]
−18.6(−31.3,−3.5)
[3]
0.0284
[4]
5
[5]
5
[6]
[10] array · 7 items
[0]
DDAH1
[1]
Dimethylarginine dimethylaminohydrolase 1
[2]
45.5(24.1,70.6)
[3]
0.0028
[4]
2
[5]
3
[6]
[11] array · 7 items
[0]
DDO
[1]
D-aspartate oxidase
[2]
−55.4(−74.7,−21.4)
[3]
0.0167
[4]
2
[5]
2
[6]
[12] array · 7 items
[0]
GOT2
[1]
Glutamatic-oxaloacetic transaminase 2, mitochondrial
[2]
−16.8(−30.0,−1.2)
[3]
0.0408
[4]
29
[5]
29
[6]
[13] array · 7 items
[0]
IVD
[1]
Isovaleryl coenzyme A dehydrogenase
[2]
−12.5(−20.2,−4.1)
[3]
0.0156
[4]
19
[5]
19
[6]
[14] array · 7 items
[0]
MCCC2
[1]
Methylcrotonoyl-coenzyme A carboxylase 2
[2]
−12.2(−20.3,−3.4)
[3]
0.0198
[4]
22
[5]
22
[6]
[15] array · 7 items
[0]
NPPA
[1]
Natriuretic polypeptide type A
[2]
−37.4(−60.1,−1.8)
[3]
0.0447
[4]
3
[5]
3
[6]
[16] array · 7 items
[0]
PTS
[1]
6-pyruvoyl-tetrahydropterin synthase
[2]
−13.6(−24.3,−1.4)
[3]
0.0375
[4]
2
[5]
2
[6]
[17] array · 7 items
[0]
ACOT7
[1]
Acyl-CoA thioesterase 7
[2]
22.0(1.2,47.2)
[3]
0.0418
[4]
5
[5]
5
[6]
Metabolism of coenzyme A
[18] array · 7 items
[0]
MCCC2
[1]
Methylcrotonoyl-coenzyme A carboxylase 2
[2]
−12.2(−20.3,−3.4)
[3]
0.0198
[4]
22
[5]
22
[6]
[19] array · 7 items
[0]
SLC27A4
[1]
Solute carrier family 27
[2]
19.4(0.9,41.2)
[3]
0.0428
[4]
3
[5]
4
[6]
[20] array · 7 items
[0]
HEXB
[1]
Hexosaminidase B
[2]
11.6(3.9,19.7)
[3]
0.0129
[4]
3
[5]
3
[6]
Metabolism of N-acetylglucosamine
[21] array · 7 items
[0]
NAGK
[1]
N-acetylglucosamine kinase
[2]
−14.7(−21.0,−7.8)
[3]
0.0047
[4]
5
[5]
5
[6]
[22] array · 7 items
[0]
CST3
[1]
Cystatin C
[2]
−32.6(−50.2,−8.7)
[3]
0.0225
[4]
3
[5]
3
[6]
Hydrolysis of protein fragments
[23] array · 7 items
[0]
CTSS
[1]
Cathepsin S
[2]
−16.6(−30.2,−0.4)
[3]
0.0470
[4]
1
[5]
1
[6]
[24] array · 7 items
[0]
CTSZ
[1]
Cathepsin Z
[2]
50.0(15.8,94.1)
[3]
0.0121
[4]
2
[5]
2
[6]
[25] array · 7 items
[0]
FBXO6
[1]
F-box protein 6
[2]
−18.8(−27.6,−8.8)
[3]
0.0075
[4]
2
[5]
2
[6]
[26] array · 7 items
[0]
HDAC6
[1]
Histone deacetylase 6
[2]
−14.0(−24.5,−2.0)
[3]
0.0324
[4]
5
[5]
5
[6]
[27] array · 7 items
[0]
IDE
[1]
Insulin degrading enzyme
[2]
6.4(1.7,11.4)
[3]
0.0188
[4]
8
[5]
8
[6]
[28] array · 7 items
[0]
MME
[1]
Membrane metallo endopeptidase
[2]
17.3(1.1.36.0)
[3]
0.0407
[4]
2
[5]
2
[6]
[29] array · 7 items
[0]
TRAF3
[1]
TNF receptor-associated factor 3
[2]
9.1(0.3,18.7)
[3]
0.0451
[4]
1
[5]
1
[6]
[30] array · 7 items
[0]
UBE2N
[1]
Ubiquitin-conjugating enzyme E2N
[2]
−11.8(−20.0,−2.7)
[3]
0.0236
[4]
7
[5]
7
[6]
[31] array · 7 items
[0]
SLC25A20
[1]
Solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20
[2]
16.7(9.2,24.6)
[3]
0.0029
[4]
14
[5]
14
[6]
Canitine acyl-carnitine translocase deficiency
[32] array · 7 items
[0]
MGLL
[1]
Monoglyceride lipase
[2]
−14.6(−27.0,−0.1)
[3]
0.0488
[4]
3
[5]
3
[6]
Hydrolysis of glycerol
[33] array · 7 items
[0]
OXCT1
[1]
3-oxoacid CoA transferase 1
[2]
−15.1(−24.1,−5.1)
[3]
0.0152
[4]
23
[5]
23
[6]
Metabolism of ketone body
[34] array · 7 items
[0]
GAPDH
[1]
Glyceraldehyde-3-phosphate dehydrogenase
[2]
−11.8(−21.3,−1.2)
[3]
0.0371
[4]
22
[5]
22
[6]
Production of glyceraldehyde- 3-phosphate
locator
section[11]/table-wrap[3]#T5
[6] object · 16 fields
id
asset:table:pmid:32528308:5
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:d4d4b2d5d8b5e6b20f840d0694d6b90e4f3698ed8b3902379b936893d9eb1922
bytes
3715
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[12]/table-wrap[1]#T3
version
null
note
Altered expression levels of proteins involved in cytoskeleton organization, cellular assembly and maintenance.
structure object · 5 fields
pmcid
PMC7247546
section_index
12
section_title
Cytoskeletal Organization, Cellular Assembly and Maintenance
row_count
38
column_count
7
table object · 8 fields
label
TABLE 3
caption
Altered expression levels of proteins involved in cytoskeleton organization, cellular assembly and maintenance.
rows array · 38 items
[0] array · 7 items
[0]
Gene
[1]
Protein
[2]
% Change (95% Confidence interval)
[3]
P-value
[4]
Unique peptides
[5]
Total peptides
[6]
Function
[1] array · 7 items
[0]
CLIP1
[1]
CAP-GLY domain containing linker protein 1
[2]
−16.3 (−29.3, −0.8)
[3]
0.0435
[4]
1
[5]
46
[6]
Stabilization of filaments
[2] array · 7 items
[0]
EML2
[1]
Echinoderm microtubule associated protein like 2
[2]
−28.9 (−40.7, −14.7)
[3]
0.0065
[4]
9
[5]
9
[6]
[3] array · 7 items
[0]
GALK2
[1]
Galactokinase 2
[2]
−6.8 (−11.1, −2.4)
[3]
0.0138
[4]
2
[5]
2
[6]
[4] array · 7 items
[0]
GAP43
[1]
Growth associated protein 43
[2]
−32.0 (−44.5, −16.6)
[3]
0.0063
[4]
4
[5]
4
[6]
[5] array · 7 items
[0]
KIFC3
[1]
Kinesin family member C3
[2]
15.8 (1.4, 32.2)
[3]
0.0373
[4]
1
[5]
1
[6]
[6] array · 7 items
[0]
MAP1B
[1]
Microtubule-associated protein 1B
[2]
−16.9 (−28.1, −3.9)
[3]
0.0242
[4]
9
[5]
9
[6]
[7] array · 7 items
[0]
ACTB
[1]
Actin, beta
[2]
−11.7 (−22.0, −0.1)
[3]
0.0485
[4]
8
[5]
28
[6]
Microtubule dynamics
[8] array · 7 items
[0]
CCL21A
[1]
Chemokine (C-C motif) ligand 21A
[2]
−21.9 (−35.9, −4.7)
[3]
0.0260
[4]
1
[5]
1
[6]
[9] array · 7 items
[0]
CLIP1
[1]
CAP-GLY domain containing linker protein 1
[2]
−16.3 (−29.3, −0.8)
[3]
0.0435
[4]
1
[5]
46
[6]
[10] array · 7 items
[0]
CRK
[1]
v-crk avian sarcoma CT10 oncogene homolog
[2]
22.2 (4.4, 43.0)
[3]
0.0242
[4]
10
[5]
10
[6]
[11] array · 7 items
[0]
CTNND1
[1]
Catenin, delta 1
[2]
−10.0 (−18.4, −0.8)
[3]
0.0397
[4]
1
[5]
13
[6]
[12] array · 7 items
[0]
CTSS
[1]
Cathepsin S
[2]
−16.6 (−30.2, −0.4)
[3]
0.0470
[4]
1
[5]
1
[6]
[13] array · 7 items
[0]
DDAH1
[1]
Dimethylarginine dimethylaminohydrolase 1
[2]
45.5 (24.1, 70.6)
[3]
0.0028
[4]
2
[5]
3
[6]
[14] array · 7 items
[0]
EIF4G2
[1]
Eukaryotic translation initiation factor 4, gamma 2
[2]
24.2 (7.9, 43.1)
[3]
0.0130
[4]
14
[5]
14
[6]
[15] array · 7 items
[0]
EML2
[1]
Echinoderm microtubule associated protein like 2
[2]
−28.9 (−40.7, −14.7)
[3]
0.0065
[4]
9
[5]
9
[6]
[16] array · 7 items
[0]
EPHA4
[1]
Eph receptor A4
[2]
14.9 (2.1, 29.3)
[3]
0.0312
[4]
3
[5]
3
[6]
[17] array · 7 items
[0]
GALK2
[1]
Galactokinase 2
[2]
−6.8 (−11.1, −2.4)
[3]
0.0138
[4]
2
[5]
2
[6]
[18] array · 7 items
[0]
GAP43
[1]
Growth associated protein 43
[2]
−32.0 (−44.5, −16.6)
[3]
0.0063
[4]
4
[5]
4
[6]
[19] array · 7 items
[0]
GAPDH
[1]
Glyceraldehyde-3-phosphate dehydrogenase
[2]
−11.8 (−21.3, −1.2)
[3]
0.0371
[4]
22
[5]
22
[6]
[20] array · 7 items
[0]
GIT1
[1]
G protein-coupled receptor kinase-interactor 1
[2]
−10.2 (−17.3, −2.4)
[3]
0.0232
[4]
5
[5]
5
[6]
[21] array · 7 items
[0]
HDAC6
[1]
Histone deacetylase 6
[2]
−14.0 (−24.5, −2.0)
[3]
0.0324
[4]
5
[5]
5
[6]
[22] array · 7 items
[0]
IDE
[1]
Insulin degrading enzyme
[2]
6.4 (1.7, 11.4)
[3]
0.0188
[4]
8
[5]
8
[6]
[23] array · 7 items
[0]
KIF1C
[1]
Kinesin family member 1C
[2]
52.6 (18.3, 96.8)
[3]
0.0100
[4]
5
[5]
6
[6]
[24] array · 7 items
[0]
KIFC3
[1]
Kinesin family member C3
[2]
15.8 (1.4, 32.2)
[3]
0.0373
[4]
1
[5]
1
[6]
[25] array · 7 items
[0]
MAP1B
[1]
Microtubule-associated protein 1B
[2]
−16.9 (−28.1, −3.9)
[3]
0.0242
[4]
9
[5]
9
[6]
[26] array · 7 items
[0]
MAPK8IP3
[1]
Mitogen-activated protein kinase 8 interacting protein 3
[2]
22.5 (2.8, 46.0)
[3]
0.0325
[4]
7
[5]
12
[6]
[27] array · 7 items
[0]
MGLL
[1]
Monoglyceride lipase
[2]
−14.6 (−27.0, −0.1)
[3]
0.0488
[4]
3
[5]
3
[6]
[28] array · 7 items
[0]
PKG1
[1]
Protein kinase, cGMP-dependent, type 1 (PKG1)
[2]
43.6 (1.5, 103.1)
[3]
0.0444
[4]
1
[5]
5
[6]
[29] array · 7 items
[0]
PRPH
[1]
Peripherin
[2]
−26.1 (−39.3, −10.1)
[3]
0.0129
[4]
9
[5]
13
[6]
[30] array · 7 items
[0]
PRUNE2
[1]
Prune homolog 2
[2]
23.1 (6.9, 41.7)
[3]
0.0148
[4]
7
[5]
7
[6]
[31] array · 7 items
[0]
PTPN11
[1]
Protein tyrosine phosphatase, non-receptor type 11
[2]
20.8 (9.1, 33.8)
[3]
0.0067
[4]
21
[5]
21
[6]
[32] array · 7 items
[0]
SIRPA
[1]
Signal-regulatory protein alpha
[2]
17.8 (5.7, 31.3)
[3]
0.0138
[4]
2
[5]
2
[6]
[33] array · 7 items
[0]
SLK
[1]
Ste20-like kinase
[2]
10.1 (2.8, 18.0)
[3]
0.0180
[4]
15
[5]
16
[6]
[34] array · 7 items
[0]
TUBB3
[1]
Tubulin, beta 3
[2]
−31.4 (−49.5, −6.9)
[3]
0.0266
[4]
2
[5]
13
[6]
[35] array · 7 items
[0]
VLDLR
[1]
Very low density lipoprotein receptor
[2]
7.6 (1.2, 14.3)
[3]
0.0291
[4]
8
[5]
8
[6]
[36] array · 7 items
[0]
DYSF
[1]
Dysferlin
[2]
−34.2 (−49.5, −14.2)
[3]
0.0118
[4]
40
[5]
42
[6]
Damage of transverse tubule
[37] array · 7 items
[0]
FHL2
[1]
Four and a half LIM domains 2
[2]
−56.0 (−79.7, −4.6)
[3]
0.0422
[4]
5
[5]
5
[6]
Cell growth and differentiation; HCM and DCM
locator
section[12]/table-wrap[1]#T3
[7] object · 16 fields
id
asset:table:pmid:32528308:6
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:df7e34dc1e48bb90484cdced89ffcf365bd877eee18369c1fa011d9aadaca6c3
bytes
2225
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[14]/table-wrap[1]#T6
version
null
note
Altered expression levels of proteins involved in various molecular pathways.
structure object · 5 fields
pmcid
PMC7247546
section_index
14
section_title
Metabolism
row_count
18
column_count
7
table object · 8 fields
label
TABLE 6
caption
Altered expression levels of proteins involved in various molecular pathways.
rows array · 18 items
[0] array · 7 items
[0]
Gene
[1]
Protein
[2]
% Change (95% Confidence interval)
[3]
P-value
[4]
Unique peptides
[5]
Total peptides
[6]
Molecular Pathways
[1] array · 7 items
[0]
CYB5A
[1]
Cytochrome b5 type A (microsomal)
[2]
−39.6 (−62.2, −3.5)
[3]
0.0405
[4]
4
[5]
4
[6]
γ-linolenate biosynthesis II
[2] array · 7 items
[0]
SLC27A4
[1]
Solute carrier family 27 (fatty acid transporter), member 4
[2]
19.4 (0.9, 41.2)
[3]
0.0428
[4]
3
[5]
4
[6]
[3] array · 7 items
[0]
ACOT2
[1]
Acyl-CoA thioesterase 2
[2]
20.4 (4.3, 39.1)
[3]
0.0231
[4]
8
[5]
15
[6]
Stearate biosynthesis I
[4] array · 7 items
[0]
ACOT7
[1]
Acyl-CoA thioesterase 7
[2]
22.0 (1.2, 47.2)
[3]
0.0418
[4]
5
[5]
5
[6]
[5] array · 7 items
[0]
SLC27A4
[1]
Solute carrier family 27 (fatty acid transporter), member 4
[2]
19.4 (0.9, 41.2)
[3]
0.0428
[4]
3
[5]
4
[6]
[6] array · 7 items
[0]
ACOT2
[1]
Acyl-CoA thioesterase 2
[2]
20.4 (4.3, 39.1)
[3]
0.0231
[4]
8
[5]
15
[6]
Acyl-CoA hydrolysis
[7] array · 7 items
[0]
ACOT7
[1]
Acyl-CoA thioesterase 7
[2]
22.0 (1.2, 47.2)
[3]
0.0418
[4]
5
[5]
5
[6]
[8] array · 7 items
[0]
NUDT12
[1]
Nudix (nucleoside diphosphate linked moiety X)-type motif 12
[2]
66.5 (15.9, 139.1)
[3]
0.0174
[4]
4
[5]
4
[6]
NAD salvage pathway II
[9] array · 7 items
[0]
NMNAT3
[1]
Nicotinamide nucleotide adenylyltransferase 3
[2]
18.9 (7.1, 32.0)
[3]
0.0100
[4]
4
[5]
4
[6]
NAD salvage pathway II and III
[10] array · 7 items
[0]
IVD
[1]
Isovaleryl coenzyme A dehydrogenase
[2]
−12.5 (−20.2, −4.1)
[3]
0.0156
[4]
19
[5]
19
[6]
Leucine degradation I
[11] array · 7 items
[0]
MCCC2
[1]
Methylcrotonoyl-coenzyme A carboxylase 2
[2]
−12.2 (−20.3, −3.4)
[3]
0.0198
[4]
22
[5]
22
[6]
[12] array · 7 items
[0]
HSD17B10
[1]
Hydroxysteroid (17-beta) dehydrogenase 10
[2]
−10.2 (−15.3, −4.8)
[3]
0.0070
[4]
14
[5]
14
[6]
Fatty Acid β-oxidation
[13] array · 7 items
[0]
IVD
[1]
Isovaleryl coenzyme A dehydrogenase
[2]
−12.5 (−20.2, −4.1)
[3]
0.0156
[4]
19
[5]
19
[6]
[14] array · 7 items
[0]
SLC27A4
[1]
Solute carrier family 27 (fatty acid transporter), member 4
[2]
19.4 (0.9, 41.2)
[3]
0.0428
[4]
3
[5]
4
[6]
[15] array · 7 items
[0]
PTPN11
[1]
Protein tyrosine phosphatase, non-receptor type 11
[2]
20.8 (9.1, 33.8)
[3]
0.0067
[4]
21
[5]
21
[6]
Role of JAK2 in hormone-like cytokine signaling
[16] array · 7 items
[0]
SIRPA
[1]
Signal-regulatory protein alpha
[2]
17.8 (5.7, 31.3)
[3]
0.0138
[4]
2
[5]
2
[6]
[17] array · 7 items
[0]
NR1D1
[1]
Nuclear receptor subfamily 1, group D, member 1
[2]
42.0 (2.2, 97.3)
[3]
0.0414
[4]
2
[5]
2
[6]
Circadian rhythm signaling
locator
section[14]/table-wrap[1]#T6
[8] object · 16 fields
id
asset:table:pmid:32528308:7
role
table
format
jats-table
media_type
application/vnd.jats.table+json
uri
null
sha256
sha256:6f8848e4fd17d6396510b72159922b41062f7496852bcd1aa0639f78fc14fb6c
bytes
779
access
open
state
verified
reader
read_table
reader_status
available
identifier
section[15]/table-wrap[1]#T7
version
null
note
Altered phosphorylation levels of identified proteins.
structure object · 5 fields
pmcid
PMC7247546
section_index
15
section_title
Altered Phosphorylation Levels
row_count
6
column_count
6
table object · 8 fields
label
TABLE 7
caption
Altered phosphorylation levels of identified proteins.
rows array · 6 items
[0] array · 6 items
[0]
Gene
[1]
Protein
[2]
Site
[3]
Domain
[4]
% Change (95% Confidence interval)
[5]
P-value
[1] array · 6 items
[0]
ANK1
[1]
Small ankyrin 1.5
[2]
Ser55
[3]
Non-modular
[4]
38.3 (4.7, 82.8)
[5]
0.0319
[2] array · 6 items
[0]
KLHDC7A
[1]
Kelch domain containing 7A
[2]
Ser361
[3]
Non-modular
[4]
194.1 (70.2, 408.2)
[5]
0.0054
[3] array · 6 items
[0]
MYH6
[1]
Myosin, heavy polypeptide 6, cardiac muscle, alpha
[2]
Ser1309
[3]
Light meromyosin (LMM)
[4]
24.9 (3.6, 50.5)
[5]
0.0299
[4] array · 6 items
[0]
UBAP2l
[1]
Ubiquitin-associated protein 2-like
[2]
Ser487
[3]
Non-modular
[4]
−53.4 (−72.3, −21.6)
[5]
0.0152
[5] array · 6 items
[0]
JPH2
[1]
Junctophilin 2
[2]
Ser597
[3]
Non-modular
[4]
−38.4 (−61.1, −2.5)
[5]
0.0428
locator
section[15]/table-wrap[1]#T7
gaps array · 2 items
[0]
asset:data:geo:PXD017314 not downloaded
[1]
asset:data:geo:PXD017314 licence not read
analysis object · 4 fields
state
complete
methods array · 1 item
[0] object · 10 fields
id
method-1
family
group_comparison
specific
anova
label
Group comparison
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
parameters object · 0 fields
data_shapes array · 1 item
[0]
two_or_more_groups_continuous
evidence object · 3 fields
score
1
band
verbatim
quote
A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States).
targets array · 0 items
gaps array · 0 items
capability object · 3 fields
state
complete
requirements array · 1 item
[0] object · 6 fields
capability_id
capability:computational_analysis
label
Computational analysis platform
assay_families array · 9 items
[0]
meta_analysis
[1]
machine_learning
[2]
survival_analysis
[3]
statistical_regression
[4]
pca
[5]
molecular_docking
[6]
network_analysis
[7]
differential_expression
[8]
gwas
candidate
Automated Assays Laravel application and simulated adapters
gaps array · 0 items
readiness object · 8 fields
state
complete
tier
R1
blocked_on
nothing:replicable_now
axes object · 3 fields
method object · 5 fields
tier
R1
expressible
true
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
missing_operations array · 0 items
basis
The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova.
capability object · 4 fields
tier
R1
capability_id
capability:computational_analysis
availability_state
owned
basis
The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here.
data object · 6 fields
tier
R1
reachable
true
accessions array · 1 item
[0]
PXD017314
resolved_accessions array · 1 item
[0]
PXD017314
statements array · 1 item
[0]
The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.
basis
The paper names PXD017314 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read.
can_run object · 3 fields
dsl_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
assets array · 9 items
[0]
source:pmid:32528308
[1]
data:geo:PXD017314
[2]
asset:table:pmid:32528308:1
[3]
asset:table:pmid:32528308:2
[4]
asset:table:pmid:32528308:3
[5]
asset:table:pmid:32528308:4
[6]
asset:table:pmid:32528308:5
[7]
asset:table:pmid:32528308:6
[8]
asset:table:pmid:32528308:7
steps array · 1 item
[0]
run_analysis
must_build object · 5 fields
dsl_operations array · 0 items
converters array · 0 items
readers array · 0 items
capabilities array · 0 items
data_gaps array · 1 item
[0]
data:geo:PXD017314
gaps array · 0 items
review object · 5 fields
state
partial
machine_critique object · 5 fields
kind
extraction_review
reader object · 5 fields
model
MiniMax-M3.1-Flash
provider
minimax
provider_family
minimax
read_at
2026-10-31T18:20:35Z
independence
single_reader
evidence_check object · 2 fields
method
verbatim
availability
verbatim
calls
3
usage object · 3 fields
prompt_tokens
55552
completion_tokens
1682
cached_tokens
18696
stages array · 1 item
[0] object · 4 fields
id
extraction
state
complete
reader
MiniMax-M3.1-Flash
provider
minimax
gaps array · 3 items
[0]
review.independent_reader
[1]
review.machine_critique
[2]
review.human_critique
execution object · 5 fields
state
absent
status
not_run
mode
null
runs array · 0 items
gaps array · 1 item
[0]
execution.not_run
provenance object · 7 fields
entities array · 3 items
[0] object · 3 fields
id
pmid:32528308
type
paper
label
pmid:32528308
[1] object · 3 fields
id
source:pmid:32528308
type
manuscript
label
PMID 32528308 full text
[2] object · 3 fields
id
data:geo:PXD017314
type
dataset
label
GEO PXD017314
activities array · 3 items
[0] object · 4 fields
id
activity-reading-sci-2026-11-01
type
classification
used array · 3 items
[0] object · 3 fields
id
pmid:32528308
type
paper
label
pmid:32528308
[1] object · 3 fields
id
source:pmid:32528308
type
manuscript
label
PMID 32528308 full text
[2] object · 3 fields
id
data:geo:PXD017314
type
dataset
label
GEO PXD017314
agent
agent:corpus-assay-engine
[1] object · 4 fields
id
activity-read-32528308
type
extraction
used array · 1 item
[0]
source:pmid:32528308
agent
agent:minimax-reader
[2] object · 4 fields
id
activity-resolve-PXD017314
type
accession_resolution
used array · 1 item
[0]
data:geo:PXD017314
agent
agent:corpus-assay-engine
agents array · 2 items
[0] object · 3 fields
id
agent:corpus-assay-engine
type
software
label
Corpus assay engine
[1] object · 3 fields
id
agent:minimax-reader
type
software
label
MiniMax literature reader
source_run_id
reading-sci-2026-11-01
dsl_catalogue_fingerprint
343fb30756ba6ec3
capability_table_fingerprint
2cb3e42f047d2ecf
snapshot_id
ba34b49490d9bfaf
lineage object · 4 fields
parent_id
pmid:32528308
parent_hash
sha256:7826e0c45ac25dcf61a99ebb6baaa2a721e6aaeaec1085ec59492654eabc9473
fork_of
null
gaps array · 6 items
[0]
asset:data:geo:PXD017314 licence not read
[1]
asset:data:geo:PXD017314 not downloaded
[2]
execution.not_run
[3]
review.human_critique
[4]
review.independent_reader
[5]
review.machine_critique
assays array · 2 items
[0] object · 11 fields
role
data_generation
definition_id
mass_spectrometry
definition_version
99e1195c7d6f
required_operations array · 0 items
support_state
partial
source_hashes object · 1 field
assay_lexicon
99e1195c7d6f
confidence
0.99
evidence array · 4 items
[0]
Proteomic Analysis of Myocardia Containing the Obscuri
[1]
old R4344Q and wild-type mice to comparative proteomics analysis using tandem mass spectrometry; raw
[2]
ere significantly altered. Moreover, phospho-proteomic evaluation revealed changes in the phosphory
[3]
comparative proteomics analysis using tandem mass spectrometry; raw data are available via ProteomeXchange
order_basis
paper_text_order:0
id
assay:1
[1] object · 11 fields
role
analysis
definition_id
group_comparison
definition_version
f2132e96ae6c7a4e
required_operations array · 4 items
[0]
group_summary
[1]
welch_t
[2]
bootstrap_mean_difference
[3]
group_comparison_anova
support_state
supported
source_hashes object · 1 field
dsl_catalogue
f2132e96ae6c7a4e
evidence array · 1 item
[0]
A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States).
order_basis
consumes_earlier_output
id
assay:2
Complete file
{"sci_version": "1.2", "schema": "https://corpus.bntrg.co.uk/sci/1.0/sci.schema.json", "id": "pmid:32528308", "kind": "science-record", "revision": 8, "content_hash": "sha256:a864d0a98bf74d2c1af7a5e1e82304ea47365a14b1f5b1b899d654a45a783496", "created_at": "2026-11-01T15:41:03Z", "updated_at": "2026-11-01T22:44:57Z", "generator": {"name": "corpus-assay-engine", "run_id": "reading-sci-2026-11-01"}, "paper": {"state": "complete", "title": "Proteomic Analysis of Myocardia Containing the Obscurin R4344Q Mutation Linked to Hypertrophic Cardiomyopathy.", "doi": "10.3389/fphys.2020.00478", "pmid": "32528308", "authors": ["Li-Yen R Hu", "Aikaterini Kontrogianni-Konstantopoulos"], "journal": "Frontiers in physiology", "year": 2020, "abstract": "Obscurin is a giant cytoskeletal protein with structural and regulatory roles encoded by the OBSCN gene. Recently, mutations in OBSCN were associated with the development of different forms of cardiomyopathies, including hypertrophic cardiomyopathy (HCM). We previously reported that homozygous mice carrying the HCM-linked R4344Q obscurin mutation develop arrhythmia by 1-year of age under sedentary conditions characterized by increased heart rate, frequent incidents of premature ventricular contractions, and episodes of spontaneous ventricular tachycardia. In an effort to delineate the molecular mechanisms that contribute to the observed arrhythmic phenotype, we subjected protein lysates prepared from left ventricles of 1-year old R4344Q and wild-type mice to comparative proteomics analysis using tandem mass spectrometry; raw data are available via ProteomeXchange with identifier PXD017314. We found that the expression levels of proteins involved in cardiac function and disease, cytoskeletal organization, electropotential regulation, molecular transport and metabolism were significantly altered. Moreover, phospho-proteomic evaluation revealed changes in the phosphorylation profile of Ca2+ cycling proteins, including sAnk1.5, a major binding partner of obscurin localized in the sarcoplasmic reticulum; notably, this is the first report indicating that sAnk1 undergoes phosphorylation. Taken together, our findings implicate obscurin in diverse cellular processes within the myocardium, which is consistent with its multiple binding partners, localization in different subcellular compartments, and disease association.", "claims": [{"id": "claim-method", "statement": "A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States).", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32528308", "locator": "sections[6] \"Data Analysis\" paragraph 2", "quote": "A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States)."}], "state": "complete"}, {"id": "claim-data-access", "statement": "The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.", "kind": "methodological", "target": null, "evidence": [{"asset": "source:pmid:32528308", "locator": "sections[16] \"Data Availability Statement\" paragraph 2", "quote": "The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher."}], "state": "complete"}], "gaps": []}, "experiment": {"state": "complete", "objective": null, "steps": [{"id": "read_published_estimate", "order": 1, "name": "Read the published estimate from the source", "kind": "other", "state": "complete", "blocked_on": null, "description": "The claim, method and evidence span published with the source article.", "duration_hours": null, "parameters": {}, "inputs": ["source:pmid:32528308"], "outputs": ["the published estimate and its evidence"], "instruments": [], "reagents": []}, {"id": "obtain_source_data", "order": 2, "name": "Obtain the source data from the named repository", "kind": "data-preparation", "state": "complete", "blocked_on": null, "description": "The GEO series accession resolves and its sample accessions are listed. This lane did not download the dataset or read its licence.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD017314"], "outputs": ["the source data with its repository provenance"], "instruments": [], "reagents": []}, {"id": "run_analysis", "order": 3, "name": "Run the published analysis", "kind": "analysis", "state": "complete", "blocked_on": null, "description": "Apply the paper's statistical method to the resolved series and compare the result with the published target.", "duration_hours": null, "parameters": {}, "inputs": ["data:geo:PXD017314"], "outputs": ["the replicated result and its comparison"], "instruments": [], "reagents": []}], "materials": [], "instruments": [], "reagents": [], "conditions": {}, "gaps": []}, "data": {"state": "partial", "assets": [{"id": "source:pmid:32528308", "role": "manuscript", "format": "xml", "media_type": "application/xml", "uri": "https://doi.org/10.3389/fphys.2020.00478", "sha256": "sha256:b66c02e467a0cbb74ae81161f02b099e3740a01d83d31748c2cd8a886ff1b32d", "bytes": 71142, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "10.3389/fphys.2020.00478", "version": null, "note": "Full article fetched from PMC; the checksum covers the rendered section body, not the original XML bytes.", "structure": {"pmcid": "PMC7247546", "source": "europe_pmc_fulltext", "coverage": "whole_body", "text_hash_scope": "rendered_section_body"}}, {"id": "data:geo:PXD017314", "role": "raw", "format": "geo-series", "media_type": "application/vnd.ncbi.geo-series+json", "uri": "https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=PXD017314", "sha256": null, "bytes": null, "access": "open", "state": "resolved", "reader": null, "reader_status": "reader_required", "identifier": "PXD017314", "version": null, "note": "The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.", "structure": {"repository": "GEO", "access_route": "GEO accession URL", "access_statement_verbatim": "The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher.", "access_statement_kind": "data_availability_statement", "sample_accessions": [], "sample_count": null, "group_sizes": null, "group_sizes_basis": null, "platform": null, "taxon": null, "title": "Proteomic analysis of left ventricles containing the obscurin R4344Q mutation linked to hypertrophic cardiomyopathy and myocardia containing obscurin lacking Immunoglobulin domains 58/59 (Ig58/59)", "resolution_checked_at": "2026-10-31T18:35:55Z", "resolution_check": "identifier_resolution_only_no_download_no_licence_read", "downloaded": false, "licence_read": false}}, {"id": "asset:table:pmid:32528308:1", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:3a8f47a125ef163414008ea0dd425aedcccd783a0013d0c80d8d9e1a4aa46ca2", "bytes": 2049, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[8]/table-wrap[1]#T1", "version": null, "note": "Altered expression levels of proteins involved in cardiac function and disease.", "structure": {"pmcid": "PMC7247546", "section_index": 8, "section_title": "Results and Discussion", "row_count": 17, "column_count": 7}, "table": {"label": "TABLE 1", "caption": "Altered expression levels of proteins involved in cardiac function and disease.", "rows": [["Gene", "Protein", "% Change (95% Confidence interval)", "P-value", "Unique peptides", "Total peptides", "Function or disease"], ["CACNA1C", "Calcium channel, voltage-dependent, L-type, alpha 1C subunit", "−16.4(−26.1,−5.6)", "0.0151", "9", "9", "Short QT syndrome; Long QT syndrome"], ["KCNQ1", "Potassium channel, voltage-gated, subfamily Q, member 1", "−19.0(−31.6,−4.2)", "0.0253", "1", "1", ""], ["ANK1", "Small Ankyrin 1.5", "44.0(2.0,103.3)", "0.0426", "1", "3", "Cardiac output"], ["DDAH1", "Dimethylarginine dimethylaminohydrolase 1", "45.5(24.1,70.6)", "0.0028", "2", "3", ""], ["NPPA", "Natriuretic polypeptide type A", "−37.4(−60.1,−1.8)", "0.0447", "3", "3", ""], ["PKG1", "Protein kinase, cGMP-dependent, type 1 (PKG1)", "43.6(1.5,103.1)", "0.0444", "1", "5", ""], ["KCNQ1", "Potassium channel, voltage-gated, subfamily Q, member 1", "−19.0(−31.6,−4.2)", "0.0253", "1", "1", "Familial atrial fibrillation"], ["NPPA", "Natriuretic polypeptide type A", "−37.4(−60.1,−1.8)", "0.0447", "3", "3", ""], ["FHL2", "Four and a half LIM domains 2", "−56.0(−79.7,−4.6)", "0.0422", "5", "5", "Relaxation of aortic ring tissue"], ["NPPA", "Natriuretic polypeptide type A", "−37.4(−60.1,−1.8)", "0.0447", "3", "3", ""], ["CACNA1C", "Calcium channel, voltage-dependent, L-type, alpha 1C subunit", "−16.4(−26.1,−5.6)", "0.0151", "9", "9", "Supraventricular tachycardia"], ["NPPA", "Natriuretic polypeptide type A", "−37.4(−60.1,−1.8)", "0.0447", "3", "3", ""], ["GUCY1A2", "Guanylate cyclase 1, alpha 2", "−16.2(−28.1,−2.5)", "0.0317", "1", "1", "Acute heart failure"], ["MME", "Membrane metallo endopeptidase", "17.3(1.1,36.0)", "0.0407", "2", "2", ""], ["DYSF", "Dysferlin", "−34.2(−49.5,−14.2)", "0.0118", "40", "42", "Early onset cardiomyopathy"], ["NPPA", "Natriuretic polypeptide type A", "−37.4(−60.1,−1.8)", "0.0447", "3", "3", "Mild congestive heart failure"]], "row_count": 17, "column_count": 7, "numeric_cells": 74, "header_rows": 1, "locator": "section[8]/table-wrap[1]#T1"}}, {"id": "asset:table:pmid:32528308:2", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:2e2ca0488c0a60c23c25055da2fa6b60886e5c1a4491b77bbc294756b3a7a34f", "bytes": 1083, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[1]#T2", "version": null, "note": "Altered expression levels of proteins involved in electropotential regulation.", "structure": {"pmcid": "PMC7247546", "section_index": 11, "section_title": "Electropotential Regulation", "row_count": 8, "column_count": 7}, "table": {"label": "TABLE 2", "caption": "Altered expression levels of proteins involved in electropotential regulation.", "rows": [["Gene", "Protein", "% Change (95% Confidence interval)", "P-value", "Unique peptides", "Total peptides", "Function"], ["KCNJ11", "Potassium inwardly rectifying channel, subfamily J, member 11 (Kir6.2)", "17.9 (0.9, 37.8)", "0.0427", "4", "4", "Transmembrane potential of cellular membrane"], ["KCNQ1", "Potassium channel, voltage-gated subfamily Q, member 1", "−19.0 (−31.6, −4.2)", "0.0253", "1", "1", ""], ["PHB", "Prohibitin", "19.8 (6.2, 35.2)", "0.0142", "15", "15", ""], ["PHB2", "Prohibitin 2", "21.5 (3.4, 42.9)", "0.0288", "20", "20", ""], ["KCNQ1", "Potassium channel, voltage-gated subfamily Q, member 1", "−19.0 (−31.6, −4.2)", "0.0253", "1", "1", "Flux of potassium"], ["NPPA", "Natriuretic polypeptide type A", "−37.4 (−60.1, −1.8)", "0.0447", "3", "3", ""], ["NPPA", "Natriuretic polypeptide type A", "−37.4 (−60.1, −1.8)", "0.0447", "3", "3", "Co-transport of chloride"]], "row_count": 8, "column_count": 7, "numeric_cells": 34, "header_rows": 1, "locator": "section[11]/table-wrap[1]#T2"}}, {"id": "asset:table:pmid:32528308:3", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:c9353cba8cca0bf8f591b491727088ea7fcd9660effb2f9ad63459902d52d8ae", "bytes": 1949, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[2]#T4", "version": null, "note": "Altered expression levels of proteins involved in molecular transport.", "structure": {"pmcid": "PMC7247546", "section_index": 11, "section_title": "Electropotential Regulation", "row_count": 19, "column_count": 7}, "table": {"label": "TABLE 4", "caption": "Altered expression levels of proteins involved in molecular transport.", "rows": [["Gene", "Protein", "% Change (95% Confidence interval)", "P-value", "Unique peptides", "Total peptides", "Function"], ["ABAT", "4-aminobutyrate aminotransferase", "−29.9 (−38.6, −19.9)", "0.0018", "8", "8", "Secretion of molecules"], ["CP", "Ceruloplasmin", "40.0 (8.4, 80.9)", "0.0217", "1", "22", ""], ["KCNJ11", "Potassium inwardly rectifying channel, subfamily J, member 11 (Kir6.2)", "17.9 (0.9, 37.8)", "0.0427", "4", "4", ""], ["KCNQ1", "Potassium channel, voltage-gated, subfamily Q, member 1", "−19.0 (−31.6, −4.2)", "0.0253", "1", "1", ""], ["MGLL", "Monoglyceride lipase", "−14.6 (−27.0, −0.1)", "0.0488", "3", "3", ""], ["NPPA", "Natriuretic polypeptide type A", "−37.4 (−60.1, −1.8)", "0.0447", "3", "3", ""], ["PHB", "Prohibitin", "19.8 (6.2, 35.2)", "0.0142", "15", "15", ""], ["PLIN2", "Perilipin2", "16.5 (2.7, 32.2)", "0.0280", "5", "5", ""], ["POFUT2", "Protein O-fucosyltransferase 2", "21.9 (1.3, 46.7)", "0.0411", "3", "3", ""], ["PKG1", "Protein kinase, cGMP-dependent, type 1 (PKG1)", "43.6 (1.5, 103.1)", "0.0444", "1", "5", ""], ["PTPN11", "Protein tyrosine phosphatase, non-receptor type 11", "20.8 (9.1, 33.8)", "0.0067", "21", "21", ""], ["RAB3B", "Rab3b", "−30.3 (−46.0, −10.0)", "0.0172", "1", "2", ""], ["SIRPA", "Signal-regulatory protein alpha", "17.8 (5.7, 31.3)", "0.0138", "2", "2", ""], ["TRAF3", "TNF receptor-associated factor 3", "9.1 (0.3, 18.7)", "0.0451", "1", "1", ""], ["GOT2", "Glutamatic-oxaloacetic transaminase 2, mitochondrial", "−16.8 (−30.0, −1.2)", "0.0408", "29", "29", "Transport of long chain fatty acids"], ["PLIN2", "Perillipin2", "16.5 (2.7, 32.2)", "0.0280", "5", "5", ""], ["SLC27A4", "Solute carrier family 27", "19.4 (0.9, 41.2)", "0.0428", "3", "4", ""], ["NPPA", "Natriuretic peptide type A", "−37.4 (−60.1, −1.8)", "0.0447", "3", "3", "Flux of water"]], "row_count": 19, "column_count": 7, "numeric_cells": 85, "header_rows": 1, "locator": "section[11]/table-wrap[2]#T4"}}, {"id": "asset:table:pmid:32528308:4", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:ed0169ce45200f3092472fee9a51af1fd996739d55aaaebb7d3ffc93dd86562b", "bytes": 3480, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[11]/table-wrap[3]#T5", "version": null, "note": "Altered expression levels of proteins involved in metabolism.", "structure": {"pmcid": "PMC7247546", "section_index": 11, "section_title": "Electropotential Regulation", "row_count": 35, "column_count": 7}, "table": {"label": "TABLE 5", "caption": "Altered expression levels of proteins involved in metabolism.", "rows": [["Gene", "Protein", "% Change (95% Confidence interval)", "P-value", "Unique peptides", "Total peptides", "Function"], ["ABAT", "4-aminobutyrate aminotransferase", "−29.9(−38.6,−19.9)", "0.0018", "8", "8", "Catabolism of lipids"], ["ACOT7", "Acyl-CoA thioesterase 7", "22.0(1.2,47.2)", "0.0418", "5", "5", ""], ["DDHD2", "DDHD domain containing 2", "30.4(0.3,69.5)", "0.0486", "1", "1", ""], ["HEXB", "Hexosaminidase B", "11.5(3.9,19.7)", "0.0129", "3", "3", ""], ["MGLL", "Monoglyceride lipase", "−14.6(−27.0,−0.1)", "0.0488", "3", "3", ""], ["SLC27A4", "Solute carrier family 27", "19.4(0.9,41.2)", "0.0428", "3", "4", ""], ["VLDLR", "Very low density lipoprotein receptor", "7.6(1.2,14.3)", "0.0291", "8", "8", ""], ["ABAT", "4-aminobutyrate aminotransferase", "−29.9(−38.6,−19.9)", "0.0018", "8", "8", "Metabolism of amino acids"], ["BCKDHB", "Branched chain ketoacid dehydrogenase E1, beta polypeptide", "−18.6(−31.3,−3.5)", "0.0284", "5", "5", ""], ["DDAH1", "Dimethylarginine dimethylaminohydrolase 1", "45.5(24.1,70.6)", "0.0028", "2", "3", ""], ["DDO", "D-aspartate oxidase", "−55.4(−74.7,−21.4)", "0.0167", "2", "2", ""], ["GOT2", "Glutamatic-oxaloacetic transaminase 2, mitochondrial", "−16.8(−30.0,−1.2)", "0.0408", "29", "29", ""], ["IVD", "Isovaleryl coenzyme A dehydrogenase", "−12.5(−20.2,−4.1)", "0.0156", "19", "19", ""], ["MCCC2", "Methylcrotonoyl-coenzyme A carboxylase 2", "−12.2(−20.3,−3.4)", "0.0198", "22", "22", ""], ["NPPA", "Natriuretic polypeptide type A", "−37.4(−60.1,−1.8)", "0.0447", "3", "3", ""], ["PTS", "6-pyruvoyl-tetrahydropterin synthase", "−13.6(−24.3,−1.4)", "0.0375", "2", "2", ""], ["ACOT7", "Acyl-CoA thioesterase 7", "22.0(1.2,47.2)", "0.0418", "5", "5", "Metabolism of coenzyme A"], ["MCCC2", "Methylcrotonoyl-coenzyme A carboxylase 2", "−12.2(−20.3,−3.4)", "0.0198", "22", "22", ""], ["SLC27A4", "Solute carrier family 27", "19.4(0.9,41.2)", "0.0428", "3", "4", ""], ["HEXB", "Hexosaminidase B", "11.6(3.9,19.7)", "0.0129", "3", "3", "Metabolism of N-acetylglucosamine"], ["NAGK", "N-acetylglucosamine kinase", "−14.7(−21.0,−7.8)", "0.0047", "5", "5", ""], ["CST3", "Cystatin C", "−32.6(−50.2,−8.7)", "0.0225", "3", "3", "Hydrolysis of protein fragments"], ["CTSS", "Cathepsin S", "−16.6(−30.2,−0.4)", "0.0470", "1", "1", ""], ["CTSZ", "Cathepsin Z", "50.0(15.8,94.1)", "0.0121", "2", "2", ""], ["FBXO6", "F-box protein 6", "−18.8(−27.6,−8.8)", "0.0075", "2", "2", ""], ["HDAC6", "Histone deacetylase 6", "−14.0(−24.5,−2.0)", "0.0324", "5", "5", ""], ["IDE", "Insulin degrading enzyme", "6.4(1.7,11.4)", "0.0188", "8", "8", ""], ["MME", "Membrane metallo endopeptidase", "17.3(1.1.36.0)", "0.0407", "2", "2", ""], ["TRAF3", "TNF receptor-associated factor 3", "9.1(0.3,18.7)", "0.0451", "1", "1", ""], ["UBE2N", "Ubiquitin-conjugating enzyme E2N", "−11.8(−20.0,−2.7)", "0.0236", "7", "7", ""], ["SLC25A20", "Solute carrier family 25 (mitochondrial carnitine/acylcarnitine translocase), member 20", "16.7(9.2,24.6)", "0.0029", "14", "14", "Canitine acyl-carnitine translocase deficiency"], ["MGLL", "Monoglyceride lipase", "−14.6(−27.0,−0.1)", "0.0488", "3", "3", "Hydrolysis of glycerol"], ["OXCT1", "3-oxoacid CoA transferase 1", "−15.1(−24.1,−5.1)", "0.0152", "23", "23", "Metabolism of ketone body"], ["GAPDH", "Glyceraldehyde-3-phosphate dehydrogenase", "−11.8(−21.3,−1.2)", "0.0371", "22", "22", "Production of glyceraldehyde- 3-phosphate"]], "row_count": 35, "column_count": 7, "numeric_cells": 159, "header_rows": 1, "locator": "section[11]/table-wrap[3]#T5"}}, {"id": "asset:table:pmid:32528308:5", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:d4d4b2d5d8b5e6b20f840d0694d6b90e4f3698ed8b3902379b936893d9eb1922", "bytes": 3715, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[12]/table-wrap[1]#T3", "version": null, "note": "Altered expression levels of proteins involved in cytoskeleton organization, cellular assembly and maintenance.", "structure": {"pmcid": "PMC7247546", "section_index": 12, "section_title": "Cytoskeletal Organization, Cellular Assembly and Maintenance", "row_count": 38, "column_count": 7}, "table": {"label": "TABLE 3", "caption": "Altered expression levels of proteins involved in cytoskeleton organization, cellular assembly and maintenance.", "rows": [["Gene", "Protein", "% Change (95% Confidence interval)", "P-value", "Unique peptides", "Total peptides", "Function"], ["CLIP1", "CAP-GLY domain containing linker protein 1", "−16.3 (−29.3, −0.8)", "0.0435", "1", "46", "Stabilization of filaments"], ["EML2", "Echinoderm microtubule associated protein like 2", "−28.9 (−40.7, −14.7)", "0.0065", "9", "9", ""], ["GALK2", "Galactokinase 2", "−6.8 (−11.1, −2.4)", "0.0138", "2", "2", ""], ["GAP43", "Growth associated protein 43", "−32.0 (−44.5, −16.6)", "0.0063", "4", "4", ""], ["KIFC3", "Kinesin family member C3", "15.8 (1.4, 32.2)", "0.0373", "1", "1", ""], ["MAP1B", "Microtubule-associated protein 1B", "−16.9 (−28.1, −3.9)", "0.0242", "9", "9", ""], ["ACTB", "Actin, beta", "−11.7 (−22.0, −0.1)", "0.0485", "8", "28", "Microtubule dynamics"], ["CCL21A", "Chemokine (C-C motif) ligand 21A", "−21.9 (−35.9, −4.7)", "0.0260", "1", "1", ""], ["CLIP1", "CAP-GLY domain containing linker protein 1", "−16.3 (−29.3, −0.8)", "0.0435", "1", "46", ""], ["CRK", "v-crk avian sarcoma CT10 oncogene homolog", "22.2 (4.4, 43.0)", "0.0242", "10", "10", ""], ["CTNND1", "Catenin, delta 1", "−10.0 (−18.4, −0.8)", "0.0397", "1", "13", ""], ["CTSS", "Cathepsin S", "−16.6 (−30.2, −0.4)", "0.0470", "1", "1", ""], ["DDAH1", "Dimethylarginine dimethylaminohydrolase 1", "45.5 (24.1, 70.6)", "0.0028", "2", "3", ""], ["EIF4G2", "Eukaryotic translation initiation factor 4, gamma 2", "24.2 (7.9, 43.1)", "0.0130", "14", "14", ""], ["EML2", "Echinoderm microtubule associated protein like 2", "−28.9 (−40.7, −14.7)", "0.0065", "9", "9", ""], ["EPHA4", "Eph receptor A4", "14.9 (2.1, 29.3)", "0.0312", "3", "3", ""], ["GALK2", "Galactokinase 2", "−6.8 (−11.1, −2.4)", "0.0138", "2", "2", ""], ["GAP43", "Growth associated protein 43", "−32.0 (−44.5, −16.6)", "0.0063", "4", "4", ""], ["GAPDH", "Glyceraldehyde-3-phosphate dehydrogenase", "−11.8 (−21.3, −1.2)", "0.0371", "22", "22", ""], ["GIT1", "G protein-coupled receptor kinase-interactor 1", "−10.2 (−17.3, −2.4)", "0.0232", "5", "5", ""], ["HDAC6", "Histone deacetylase 6", "−14.0 (−24.5, −2.0)", "0.0324", "5", "5", ""], ["IDE", "Insulin degrading enzyme", "6.4 (1.7, 11.4)", "0.0188", "8", "8", ""], ["KIF1C", "Kinesin family member 1C", "52.6 (18.3, 96.8)", "0.0100", "5", "6", ""], ["KIFC3", "Kinesin family member C3", "15.8 (1.4, 32.2)", "0.0373", "1", "1", ""], ["MAP1B", "Microtubule-associated protein 1B", "−16.9 (−28.1, −3.9)", "0.0242", "9", "9", ""], ["MAPK8IP3", "Mitogen-activated protein kinase 8 interacting protein 3", "22.5 (2.8, 46.0)", "0.0325", "7", "12", ""], ["MGLL", "Monoglyceride lipase", "−14.6 (−27.0, −0.1)", "0.0488", "3", "3", ""], ["PKG1", "Protein kinase, cGMP-dependent, type 1 (PKG1)", "43.6 (1.5, 103.1)", "0.0444", "1", "5", ""], ["PRPH", "Peripherin", "−26.1 (−39.3, −10.1)", "0.0129", "9", "13", ""], ["PRUNE2", "Prune homolog 2", "23.1 (6.9, 41.7)", "0.0148", "7", "7", ""], ["PTPN11", "Protein tyrosine phosphatase, non-receptor type 11", "20.8 (9.1, 33.8)", "0.0067", "21", "21", ""], ["SIRPA", "Signal-regulatory protein alpha", "17.8 (5.7, 31.3)", "0.0138", "2", "2", ""], ["SLK", "Ste20-like kinase", "10.1 (2.8, 18.0)", "0.0180", "15", "16", ""], ["TUBB3", "Tubulin, beta 3", "−31.4 (−49.5, −6.9)", "0.0266", "2", "13", ""], ["VLDLR", "Very low density lipoprotein receptor", "7.6 (1.2, 14.3)", "0.0291", "8", "8", ""], ["DYSF", "Dysferlin", "−34.2 (−49.5, −14.2)", "0.0118", "40", "42", "Damage of transverse tubule"], ["FHL2", "Four and a half LIM domains 2", "−56.0 (−79.7, −4.6)", "0.0422", "5", "5", "Cell growth and differentiation; HCM and DCM"]], "row_count": 38, "column_count": 7, "numeric_cells": 179, "header_rows": 1, "locator": "section[12]/table-wrap[1]#T3"}}, {"id": "asset:table:pmid:32528308:6", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:df7e34dc1e48bb90484cdced89ffcf365bd877eee18369c1fa011d9aadaca6c3", "bytes": 2225, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[14]/table-wrap[1]#T6", "version": null, "note": "Altered expression levels of proteins involved in various molecular pathways.", "structure": {"pmcid": "PMC7247546", "section_index": 14, "section_title": "Metabolism", "row_count": 18, "column_count": 7}, "table": {"label": "TABLE 6", "caption": "Altered expression levels of proteins involved in various molecular pathways.", "rows": [["Gene", "Protein", "% Change (95% Confidence interval)", "P-value", "Unique peptides", "Total peptides", "Molecular Pathways"], ["CYB5A", "Cytochrome b5 type A (microsomal)", "−39.6 (−62.2, −3.5)", "0.0405", "4", "4", "γ-linolenate biosynthesis II"], ["SLC27A4", "Solute carrier family 27 (fatty acid transporter), member 4", "19.4 (0.9, 41.2)", "0.0428", "3", "4", ""], ["ACOT2", "Acyl-CoA thioesterase 2", "20.4 (4.3, 39.1)", "0.0231", "8", "15", "Stearate biosynthesis I"], ["ACOT7", "Acyl-CoA thioesterase 7", "22.0 (1.2, 47.2)", "0.0418", "5", "5", ""], ["SLC27A4", "Solute carrier family 27 (fatty acid transporter), member 4", "19.4 (0.9, 41.2)", "0.0428", "3", "4", ""], ["ACOT2", "Acyl-CoA thioesterase 2", "20.4 (4.3, 39.1)", "0.0231", "8", "15", "Acyl-CoA hydrolysis"], ["ACOT7", "Acyl-CoA thioesterase 7", "22.0 (1.2, 47.2)", "0.0418", "5", "5", ""], ["NUDT12", "Nudix (nucleoside diphosphate linked moiety X)-type motif 12", "66.5 (15.9, 139.1)", "0.0174", "4", "4", "NAD salvage pathway II"], ["NMNAT3", "Nicotinamide nucleotide adenylyltransferase 3", "18.9 (7.1, 32.0)", "0.0100", "4", "4", "NAD salvage pathway II and III"], ["IVD", "Isovaleryl coenzyme A dehydrogenase", "−12.5 (−20.2, −4.1)", "0.0156", "19", "19", "Leucine degradation I"], ["MCCC2", "Methylcrotonoyl-coenzyme A carboxylase 2", "−12.2 (−20.3, −3.4)", "0.0198", "22", "22", ""], ["HSD17B10", "Hydroxysteroid (17-beta) dehydrogenase 10", "−10.2 (−15.3, −4.8)", "0.0070", "14", "14", "Fatty Acid β-oxidation"], ["IVD", "Isovaleryl coenzyme A dehydrogenase", "−12.5 (−20.2, −4.1)", "0.0156", "19", "19", ""], ["SLC27A4", "Solute carrier family 27 (fatty acid transporter), member 4", "19.4 (0.9, 41.2)", "0.0428", "3", "4", ""], ["PTPN11", "Protein tyrosine phosphatase, non-receptor type 11", "20.8 (9.1, 33.8)", "0.0067", "21", "21", "Role of JAK2 in hormone-like cytokine signaling"], ["SIRPA", "Signal-regulatory protein alpha", "17.8 (5.7, 31.3)", "0.0138", "2", "2", ""], ["NR1D1", "Nuclear receptor subfamily 1, group D, member 1", "42.0 (2.2, 97.3)", "0.0414", "2", "2", "Circadian rhythm signaling"]], "row_count": 18, "column_count": 7, "numeric_cells": 88, "header_rows": 1, "locator": "section[14]/table-wrap[1]#T6"}}, {"id": "asset:table:pmid:32528308:7", "role": "table", "format": "jats-table", "media_type": "application/vnd.jats.table+json", "uri": null, "sha256": "sha256:6f8848e4fd17d6396510b72159922b41062f7496852bcd1aa0639f78fc14fb6c", "bytes": 779, "access": "open", "state": "verified", "reader": "read_table", "reader_status": "available", "identifier": "section[15]/table-wrap[1]#T7", "version": null, "note": "Altered phosphorylation levels of identified proteins.", "structure": {"pmcid": "PMC7247546", "section_index": 15, "section_title": "Altered Phosphorylation Levels", "row_count": 6, "column_count": 6}, "table": {"label": "TABLE 7", "caption": "Altered phosphorylation levels of identified proteins.", "rows": [["Gene", "Protein", "Site", "Domain", "% Change (95% Confidence interval)", "P-value"], ["ANK1", "Small ankyrin 1.5", "Ser55", "Non-modular", "38.3 (4.7, 82.8)", "0.0319"], ["KLHDC7A", "Kelch domain containing 7A", "Ser361", "Non-modular", "194.1 (70.2, 408.2)", "0.0054"], ["MYH6", "Myosin, heavy polypeptide 6, cardiac muscle, alpha", "Ser1309", "Light meromyosin (LMM)", "24.9 (3.6, 50.5)", "0.0299"], ["UBAP2l", "Ubiquitin-associated protein 2-like", "Ser487", "Non-modular", "−53.4 (−72.3, −21.6)", "0.0152"], ["JPH2", "Junctophilin 2", "Ser597", "Non-modular", "−38.4 (−61.1, −2.5)", "0.0428"]], "row_count": 6, "column_count": 6, "numeric_cells": 21, "header_rows": 1, "locator": "section[15]/table-wrap[1]#T7"}}], "gaps": ["asset:data:geo:PXD017314 not downloaded", "asset:data:geo:PXD017314 licence not read"]}, "analysis": {"state": "complete", "methods": [{"id": "method-1", "family": "group_comparison", "specific": "anova", "label": "Group comparison", "dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "expressible": true, "parameters": {}, "data_shapes": ["two_or_more_groups_continuous"], "evidence": {"score": 1.0, "band": "verbatim", "quote": "A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States)."}}], "targets": [], "gaps": []}, "capability": {"state": "complete", "requirements": [{"capability_id": "capability:computational_analysis", "label": "Computational analysis platform", "assay_families": ["meta_analysis", "machine_learning", "survival_analysis", "statistical_regression", "pca", "molecular_docking", "network_analysis", "differential_expression", "gwas"], "availability_state": "owned", "tier_unlocked": "R1", "candidate": "Automated Assays Laravel application and simulated adapters"}], "gaps": []}, "readiness": {"state": "complete", "tier": "R1", "blocking_axis": "none", "blocked_on": "nothing:replicable_now", "axes": {"method": {"tier": "R1", "expressible": true, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "missing_operations": [], "basis": "The paper names the method it used and the corpus's method extractor maps it onto the DSL catalogue: anova."}, "capability": {"tier": "R1", "capability_id": "capability:computational_analysis", "availability_state": "owned", "basis": "The computational analysis is owned. The physical bench the paper used is not, so a physical validation cannot be run here."}, "data": {"tier": "R1", "reachable": true, "accessions": ["PXD017314"], "resolved_accessions": ["PXD017314"], "statements": ["The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation, to any qualified researcher."], "basis": "The paper names PXD017314 in ProteomeXchange Consortium via the PRIDE partner repository and the accession resolves in the repository. No dataset was downloaded and no licence was read."}}, "can_run": {"dsl_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "assets": ["source:pmid:32528308", "data:geo:PXD017314", "asset:table:pmid:32528308:1", "asset:table:pmid:32528308:2", "asset:table:pmid:32528308:3", "asset:table:pmid:32528308:4", "asset:table:pmid:32528308:5", "asset:table:pmid:32528308:6", "asset:table:pmid:32528308:7"], "steps": ["run_analysis"]}, "must_build": {"dsl_operations": [], "converters": [], "readers": [], "capabilities": [], "data_gaps": ["data:geo:PXD017314"]}, "gaps": []}, "review": {"state": "partial", "machine_critique": {"kind": "extraction_review", "reader": {"model": "MiniMax-M3.1-Flash", "provider": "minimax", "provider_family": "minimax", "read_at": "2026-10-31T18:20:35Z", "independence": "single_reader"}, "evidence_check": {"method": "verbatim", "availability": "verbatim"}, "calls": 3, "usage": {"prompt_tokens": 55552, "completion_tokens": 1682, "cached_tokens": 18696}}, "human_critique": null, "stages": [{"id": "extraction", "state": "complete", "reader": "MiniMax-M3.1-Flash", "provider": "minimax"}], "gaps": ["review.independent_reader", "review.machine_critique", "review.human_critique"]}, "execution": {"state": "absent", "status": "not_run", "mode": null, "runs": [], "gaps": ["execution.not_run"]}, "provenance": {"entities": [{"id": "pmid:32528308", "type": "paper", "label": "pmid:32528308"}, {"id": "source:pmid:32528308", "type": "manuscript", "label": "PMID 32528308 full text"}, {"id": "data:geo:PXD017314", "type": "dataset", "label": "GEO PXD017314"}], "activities": [{"id": "activity-reading-sci-2026-11-01", "type": "classification", "used": [{"id": "pmid:32528308", "type": "paper", "label": "pmid:32528308"}, {"id": "source:pmid:32528308", "type": "manuscript", "label": "PMID 32528308 full text"}, {"id": "data:geo:PXD017314", "type": "dataset", "label": "GEO PXD017314"}], "agent": "agent:corpus-assay-engine"}, {"id": "activity-read-32528308", "type": "extraction", "used": ["source:pmid:32528308"], "agent": "agent:minimax-reader"}, {"id": "activity-resolve-PXD017314", "type": "accession_resolution", "used": ["data:geo:PXD017314"], "agent": "agent:corpus-assay-engine"}], "agents": [{"id": "agent:corpus-assay-engine", "type": "software", "label": "Corpus assay engine"}, {"id": "agent:minimax-reader", "type": "software", "label": "MiniMax literature reader"}], "source_run_id": "reading-sci-2026-11-01", "dsl_catalogue_fingerprint": "343fb30756ba6ec3", "capability_table_fingerprint": "2cb3e42f047d2ecf", "snapshot_id": "ba34b49490d9bfaf"}, "lineage": {"parent_id": "pmid:32528308", "parent_hash": "sha256:7826e0c45ac25dcf61a99ebb6baaa2a721e6aaeaec1085ec59492654eabc9473", "fork_of": null, "generation": 7}, "gaps": ["asset:data:geo:PXD017314 licence not read", "asset:data:geo:PXD017314 not downloaded", "execution.not_run", "review.human_critique", "review.independent_reader", "review.machine_critique"], "assays": [{"role": "data_generation", "definition_id": "mass_spectrometry", "definition_version": "99e1195c7d6f", "definition_digest": null, "required_operations": [], "support_state": "partial", "source_hashes": {"assay_lexicon": "99e1195c7d6f"}, "confidence": 0.99, "evidence": ["Proteomic Analysis of Myocardia Containing the Obscuri", "old R4344Q and wild-type mice to comparative proteomics analysis using tandem mass spectrometry; raw", "ere significantly altered. Moreover, phospho-proteomic evaluation revealed changes in the phosphory", "comparative proteomics analysis using tandem mass spectrometry; raw data are available via ProteomeXchange"], "order_basis": "paper_text_order:0", "id": "assay:1"}, {"role": "analysis", "definition_id": "group_comparison", "definition_version": "f2132e96ae6c7a4e", "definition_digest": null, "required_operations": ["group_summary", "welch_t", "bootstrap_mean_difference", "group_comparison_anova"], "support_state": "supported", "source_hashes": {"dsl_catalogue": "f2132e96ae6c7a4e"}, "confidence": 1.0, "evidence": ["A two-tailed t-test using a one-way ANOVA model was applied to evaluate the adjusted modified peptides between wild-type and R4344Q LV samples using the Partek Genomics Suite 6.6 analytic platform (Partek Inc. St. Louis, MO, United States)."], "order_basis": "consumes_earlier_output", "id": "assay:2"}]}